Recombinant protein · Protein replacement: asparagine · developed by Sigma Tau
Pegaspargase is a polyethylene glycol conjugated L-asparaginase enzyme that hydrolyzes the amino acid L-asparagine into aspartic acid and ammonia. Leukemic cells with low asparagine synthetase expression depend on external asparagine, so its depletion blocks protein synthesis and induces apoptosis in these cells. It is used in acute lymphoblastic leukemia.
Summary written with AI from the sources listed at the end of this page.
From the indications section of the FDA label (version of Oct 7, 2024). Read the full label for the exact wording, limitations and safety information.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT05848687 | Phase 1/2 | Lymphoblastic Leukemia | Recruiting | KURA |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Lymphoblastic Leukemia
Updated Oct 18, 2026.